{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-027387","form_type":"8-K","ticker":"SONM","cik":"0001178697","company_name":"DNA X, Inc.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.321272+00:00","generated_at":"2026-06-11T21:30:45.617364+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sonim board members Alan Howe and Jose Principe to retire; Howe to remain as consultant","bullets":["Alan Howe and Jose Principe will not stand for re-election at Sonim's 2023 annual meeting.","Howe signed a one-year consulting agreement with a $25,000 annual retainer, effective after the meeting.","Howe's unvested equity awards will continue vesting as if he remained on the board.","Both retirements are not due to any disagreement with company operations or policies.","Consulting agreement includes confidentiality, non-disclosure, and non-disparagement covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-027387","json":"https://secwatch.observer/filing/0001493152-23-027387.json","markdown":"https://secwatch.observer/filing/0001493152-23-027387.md","text":"https://secwatch.observer/filing/0001493152-23-027387.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223027387/0001493152-23-027387-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223027387/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T21:30:45.617364+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01fcd8d01b","claim":"Alan Howe retired as Director at DNA X, Inc..","evidence_excerpt":"On August 3, 2023, Alan Howe informed the board of directors (the “Board”) of Sonim Technologies, Inc. (the “Company”) of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223027387/0001493152-23-027387-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"74f97e645a","claim":"Jose C. Principe retired as Director at DNA X, Inc..","evidence_excerpt":"On August 3, 2023, Jose C. Principe informed the Board of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223027387/0001493152-23-027387-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}